Comparative EEG mapping studies in Huntington's disease patients and controls.

Area of Science:

• Neuroscience
• Clinical Neurophysiology

Background:

• Huntington's disease (HD) is a severe neurodegenerative disorder causing motor and cognitive deficits.
• Previous electroencephalogram (EEG) studies in HD have been limited by small sample sizes and methodological issues.

Purpose of the Study:

• To quantitatively assess neurophysiological differences in HD patients compared to healthy controls using EEG mapping.
• To investigate the relationship between EEG abnormalities and clinical symptoms in HD.

Main Methods:

• A vigilance-controlled EEG (V-EEG) was recorded from 55 HD patients and 55 controls.
• Spectral analysis and EEG mapping evaluated 36 EEG variables.
• Analysis considered medication effects, including unmedicated patients and comparisons between treated and untreated groups.

Main Results:

• Significant EEG differences were found between HD patients and controls (p < 0.01 and p < 0.05).
• HD patients showed decreased total, alpha, and beta power, increased delta/theta power, and slowed power centroids.
• EEG slowing suggests vigilance decrement, inhibited cortical activity, and reduced excitatory function in HD.

Conclusions:

• Quantitative EEG mapping reveals significant neurophysiological disturbances in Huntington's disease.
• These EEG findings in HD resemble those in other dementing disorders.
• EEG alterations correlate with motor and cognitive impairments, offering potential biomarkers for disease progression.